Literature DB >> 16509846

Postirradiation morphea in a breast cancer patient.

Steve Dubner1, Joseph Bovi, Julia White, Barbara Susnik.   

Abstract

We present the case of a 52-year-old woman who underwent lumpectomy and radiation therapy for breast carcinoma and 2 years later presented with changes limited to the breast radiation field including hyperpigmentation, retraction, and skin thickening. These clinical features, along with pathologic findings, were diagnostic of postirradiation morphea. It is important to be aware of this rare complication of radiation therapy because it clinically presents with symptoms mimicking malignancy and may be misinterpreted as recurrent carcinoma or even angiosarcoma.

Entities:  

Mesh:

Year:  2006        PMID: 16509846     DOI: 10.1111/j.1075-122X.2006.00229.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  4 in total

1.  Post-Irradiation Morphea: Case report and review of the literature.

Authors:  Ammar Alhathlool; Rüdiger Hein; Christian Andres; Johannes Ring; Bernadette Eberlein
Journal:  J Dermatol Case Rep       Date:  2012-09-28

2.  Localized morphea--a rare but significant secondary complication following breast cancer radiotherapy. Case report and review of the literature on radiation reaction among patients with scleroderma/morphea.

Authors:  Thomas Herrmann; Claudia Günther; Peter Csere
Journal:  Strahlenther Onkol       Date:  2009-09-12       Impact factor: 3.621

3.  Post-Irradiation Morphea of the Breast in a Patient with Subacute Cutaneous Lupus Erythematosus: Case Report and a Literature Review.

Authors:  Carole Anouk Zahn; Laurence Feldmeyer; Roland Blum; Carlo Mainetti
Journal:  Case Rep Dermatol       Date:  2022-05-30

4.  Radiation-induced morphea-a rare but severe late effect of adjuvant breast irradiation : Case report and review of the literature.

Authors:  Richard Partl; Peter Regitnig; Gerlinde Tauber; Michaela Pötscher; Vesna Bjelic-Radisic; Karin S Kapp
Journal:  Strahlenther Onkol       Date:  2018-07-16       Impact factor: 3.621

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.